News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
604,619 Results
Type
Article (27341)
Company Profile (155)
Press Release (577445)
Multimedia
Podcasts (35)
Webinars (9)
Section
Business (191386)
Career Advice (797)
Deals (29268)
Drug Delivery (74)
Drug Development (68736)
Employer Resources (67)
FDA (13622)
Job Trends (11266)
News (284708)
Policy (24626)
Tag
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (1728)
Accelerated approval (39)
ADA (50)
Adcomms (14)
Allergies (146)
Alliances (39109)
ALS (171)
Alzheimer's disease (1468)
Antibody-drug conjugate (ADC) (378)
Approvals (14222)
Artificial intelligence (439)
ASCO (333)
Autoimmune disease (271)
Automation (45)
Bankruptcy (297)
Best Places to Work (9280)
BIO (54)
BIOSECURE Act (13)
Biosimilars (166)
Biotechnology (101)
Bladder cancer (185)
Brain cancer (56)
Breast cancer (666)
Cancer (5132)
Cardiovascular disease (408)
Career advice (643)
Career pathing (7)
CAR-T (294)
CDC (35)
Celiac Disease (2)
Cell therapy (761)
Cervical cancer (50)
Clinical research (61041)
Collaboration (1541)
Commercialization (1)
Compensation (1451)
Complete response letters (54)
COVID-19 (1649)
CRISPR (88)
C-suite (871)
Cystic fibrosis (117)
Data (7476)
Decentralized trials (3)
Denatured (5)
Depression (126)
Dermatology (81)
Diabetes (587)
Diagnostics (6031)
Digital health (46)
Diversity (2)
Diversity, equity & inclusion (20)
Drug discovery (212)
Drug pricing (128)
Drug shortages (11)
Duchenne muscular dystrophy (224)
Earnings (79724)
Editorial (41)
Employer branding (8)
Employer resources (62)
Events (104999)
Executive appointments (824)
FDA (16929)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (27)
Funding (1227)
Gene editing (180)
Generative AI (21)
Gene therapy (509)
GLP-1 (751)
Government (2666)
Grass and pollen (5)
Guidances (350)
Healthcare (14585)
Hematology (179)
HIV (60)
Huntington's disease (38)
IgA nephropathy (100)
Immunology and inflammation (164)
Immuno-oncology (84)
Indications (191)
Infectious disease (1901)
Inflammatory bowel disease (169)
Inflation Reduction Act (11)
Influenza (99)
Intellectual property (274)
Interviews (84)
IPO (13956)
IRA (32)
Job creations (2430)
Job search strategy (601)
JPM (18)
Kidney cancer (22)
Labor market (10)
Layoffs (161)
Leadership (8)
Legal (6327)
Liver cancer (79)
Longevity (22)
Lung cancer (704)
Lymphoma (431)
Machine learning (38)
Management (25)
Manufacturing (731)
Marketing (8)
MASH (152)
Medical device (11158)
Medtech (11307)
Mergers & acquisitions (16419)
Metabolic disorders (1241)
mRNA (109)
Multiple sclerosis (162)
NASH (8)
Neurodegenerative disease (329)
Neuropsychiatric disorders (65)
Neuroscience (2676)
NextGen: Class of 2026 (4700)
Non-profit (3145)
Now hiring (4)
Obesity (494)
Opinion (119)
Ovarian cancer (197)
Pain (224)
Pancreatic cancer (290)
Parkinson's disease (275)
Partnered (18)
Patents (524)
Patient recruitment (600)
Peanut (57)
People (48748)
Pharmaceutical (36)
Pharmacy benefit managers (25)
Phase 1 (18941)
Phase 2 (26600)
Phase 3 (19794)
Pipeline (8409)
Policy (185)
Postmarket research (2467)
Preclinical (8241)
Press Release (44)
Prostate cancer (268)
Psychedelics (15)
Radiopharmaceuticals (246)
Rare diseases (885)
Real estate (3919)
Recruiting (20)
Regulatory (19994)
Reports (23)
Research institute (1590)
Resumes & cover letters (136)
Rett syndrome (41)
RNA editing (14)
RSV (57)
Schizophrenia (144)
Series A (192)
Series B (160)
Service/supplier (4)
Sickle cell disease (119)
Special edition (8)
Spinal muscular atrophy (128)
Sponsored (18)
Startups (2477)
Stomach cancer (5)
Supply chain (76)
Tariffs (35)
The Weekly (30)
Vaccines (646)
Venture capital (48)
Weight loss (282)
Women's health (101)
Worklife (5)
Date
Last 7 days (344)
Last 30 days (1421)
Last 365 days (24061)
2026 (13776)
2025 (24257)
2024 (28501)
2023 (32531)
2022 (42668)
2021 (45926)
2020 (43244)
2019 (34040)
2018 (25887)
2017 (24425)
2016 (24150)
2015 (30560)
2014 (26202)
2013 (22059)
2012 (24316)
2011 (24780)
2010 (24279)
Location
Africa (427)
Alabama (78)
Alaska (4)
Arizona (328)
Arkansas (14)
Asia (26828)
Australia (4010)
California (12812)
Canada (3479)
China (933)
Colorado (537)
Connecticut (463)
Delaware (357)
Europe (50631)
Florida (1904)
Georgia (411)
Hawaii (2)
Idaho (57)
Illinois (954)
India (69)
Indiana (485)
Iowa (17)
Japan (476)
Kansas (117)
Kentucky (35)
Louisiana (53)
Maine (31)
Maryland (1389)
Massachusetts (8808)
Michigan (329)
Minnesota (671)
Mississippi (4)
Missouri (117)
Montana (22)
Nebraska (14)
Nevada (120)
New Hampshire (66)
New Jersey (3222)
New Mexico (20)
New York (3159)
North Carolina (1463)
North Dakota (7)
Northern California (6486)
Ohio (318)
Oklahoma (21)
Oregon (24)
Pennsylvania (2424)
Puerto Rico (25)
Rhode Island (42)
South America (818)
South Carolina (77)
South Dakota (1)
Southern California (5203)
Tennessee (194)
Texas (2045)
United States (43532)
Utah (376)
Vermont (2)
Virginia (236)
Washington D.C. (52)
Washington State (1001)
West Virginia (1)
Wisconsin (98)
604,619 Results for "cord blood america inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia
April 27, 2026
·
5 min read
Press Releases
BIOTRONIK Neuro Acquires Spinal Cord Stimulation System from Soin Neuroscience
July 16, 2026
·
4 min read
Press Releases
StemCyte Announces FDA Clearance of Expanded Access Program for RegeneCyte® (HPC, Cord Blood) to Address Unmet Need in Long COVID
January 27, 2026
·
2 min read
Press Releases
C2N Diagnostics and SouthGenetics Partner to Enable Broader Access to Precivity® Blood Tests for Alzheimer’s Disease Assessment in Latin America, Caribbean
June 2, 2026
·
6 min read
Approvals
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer
Decnupaz is the first antibody-drug conjugate for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare and aggressive blood cancer.
May 28, 2026
·
1 min read
·
Tristan Manalac
Press Releases
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
February 4, 2026
·
7 min read
Neuroscience
NervGen’s Peptide Achieves Nervous System Repair in Phase II Spinal Cord Injury Study
NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord injury.
November 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
New study could improve testing and treatment for rare brain, spinal cord, and eye cancers
May 21, 2026
·
4 min read
Press Releases
Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury
July 1, 2026
·
7 min read
Press Releases
NeuroLife® Launch Brings Non-Invasive Technology Aimed at Restoring Hand and Arm Movement After Stroke and Spinal Cord Injury
June 25, 2026
·
3 min read
1 of 60,462
Next
